Lastly, there are several clinical factors the Agency encourages sponsors to consider. One way psychedelics differ from other drugs is that the use of a traditional placebo as a control may be challenging, as an active drug...more
The FDA has been continuing to work on protecting medical devices from the threats of cybersecurity. In April of this year, the Agency released the latest draft guidance addressing cybersecurity in the medical device...more
8/17/2022
/ Connected Items ,
Cyber Attacks ,
Cybersecurity ,
Draft Guidance ,
Food and Drug Administration (FDA) ,
Health Information Technologies ,
Healthcare ,
Life Sciences ,
Manufacturers ,
Medical Devices ,
Patient Privacy Rights ,
Patient Safety ,
Pharmaceutical Industry ,
Popular ,
Risk Management ,
Vulnerability Assessments